EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib

Shiting Li, Hongqin Wang

Drug Design, Development and Therapy · 2023-11 · Volume 17 · 3429-3437

DOI: 10.2147/dddt.s426898 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2023-11. Verfasst von Shiting Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Inner Mongolia Baogang Hospital, Baotou City, Inner, Mongolia, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Drug-Related Side Effects and Adverse Reactions, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungDrug-Related Side Effects and Adverse ReactionsEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaKidney NeoplasmsLung NeoplasmsQuinolinesHumansClinical Trials, Phase III as TopicIndoles

Stichwörter der Autor:innen

adverse drug reactionanlotinibanti-angiogenesisanti-cancer mechanismnon-small cell lung cancer

Substanzen

QuinolinesanlotinibIndoles

Autor:innen und Institutionen

  • Department of Pharmacy, Inner Mongolia Baogang Hospital, Baotou City, Inner, Mongolia, People's Republic of China.

Zitieren

APA

Li, S., & Wang, H. (2023). Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib. Drug Design, Development and Therapy, Volume 17, 3429-3437. https://doi.org/10.2147/dddt.s426898

Vancouver

Li S, Wang H. Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib. Drug Design, Development and Therapy. 2023;Volume 17:3429-3437. doi:10.2147/dddt.s426898

BibTeX
@article{Li2023,
  author = {Li, Shiting and Wang, Hongqin},
  title = {Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  volume = {Volume 17},
  pages = {3429--3437},
  doi = {10.2147/dddt.s426898}
}
Kostenlos starten →